A rival to trendy weight loss drug semaglutide has been shown to drastically improve people's blood pressure after 36 weeks of taking the medication, according to a new study published in the journal Hypertension. The medication is called tirzepatide, developed by the big pharmaceutical company Eli Lilly, which the Federal Drug Administration approved a few […]
Not everyone can tolerate statins to reduce their high cholesterol, but now a new study finds the medication bempedoic acid (Nexletol) reduced the combined rate of bad cardiovascular events by 13%.
Bempedoic acid lowers cholesterol, and a study found a modest effect on cardiac illness. But whether patients are any more willing to take it remains to be seen, experts said.